Lab result explainedLiverLast updated November 10, 2026

Direct bilirubin: what a high conjugated bilirubin means and how it differs from indirect

Direct (conjugated) bilirubin (Direct bilirubin) · Liver panel (hepatic function panel), comprehensive metabolic panel with fractionated bilirubin · reported in mg/dL (SI µmol/L; 1 mg/dL = 17.1 µmol/L)

Direct bilirubin, also called conjugated bilirubin, is the portion of bilirubin that the liver has already processed and made water-soluble so that it can be excreted into bile. Bilirubin itself is the yellow pigment left over when old red blood cells are broken down. A liver panel reports total bilirubin and direct bilirubin and subtracts one from the other to give indirect (unconjugated) bilirubin. In healthy adults direct bilirubin is 0 to 0.3 mg/dL and makes up well under a fifth of the total, with small differences between laboratories.

A high direct bilirubin means the liver has done its job of conjugating the pigment but cannot get it out: either bile flow is blocked somewhere between the liver cells and the intestine (gallstones in the bile duct, a tumor of the pancreas or bile duct, scarring from primary biliary cholangitis or primary sclerosing cholangitis), or the liver cells themselves are injured and leaking (viral hepatitis, alcohol, drugs, sepsis). Because conjugated bilirubin dissolves in water, it spills into the urine, so dark tea-colored urine is often the first sign, before the skin turns yellow. A high indirect bilirubin, by contrast, means too much pigment is being produced (hemolysis) or the liver cannot conjugate it fast enough (Gilbert's syndrome, newborns), and it does not appear in urine.

Splitting bilirubin into direct and indirect is the first fork in working out why bilirubin is high, and it changes what happens next. A raised direct fraction nearly always leads to an ultrasound of the liver and bile ducts, with the pattern of alkaline phosphatase, GGT, ALT and AST deciding whether the problem looks like obstruction or liver cell injury. In newborns a direct bilirubin above 1.0 mg/dL is abnormal at any total and needs prompt evaluation for biliary atresia, which is treatable only if found early.

Direct bilirubin at a glance

What it is: bilirubin that the liver has conjugated (attached to glucuronic acid) so it can pass into bile; it is water-soluble and shows up in urine when high.
Normal (adults): 0.0–0.3 mg/dL direct, with total bilirubin 0.1–1.2 mg/dL; some labs set the direct limit at 0.2 or 0.4 mg/dL.
A raised total bilirubin is called conjugated (direct) hyperbilirubinemia when the direct fraction is more than about 50 percent of the total; under 20 percent is unconjugated; 20 to 50 percent is mixed.
High direct bilirubin: bile duct obstruction (gallstones, pancreatic or bile duct cancer, strictures), liver cell injury (viral or alcoholic hepatitis, drug-induced liver injury), cholestasis from sepsis, pregnancy or medications, cirrhosis, and the harmless inherited Dubin-Johnson and Rotor syndromes.
Infants: a direct bilirubin above 1.0 mg/dL is abnormal whatever the total and must be evaluated urgently for biliary atresia.
Next step: alkaline phosphatase, GGT, ALT, AST, albumin and INR to define the pattern, a urine dipstick for bilirubin, and an ultrasound of the liver and bile ducts within days; same-day care if there is fever, severe pain or confusion.

Have your whole report? Paste it into the free Lab Explainer

Every marker explained in plain language, in context with the others, with questions to bring to your appointment. No account needed.

What Direct bilirubin measures

About 250 to 350 mg of bilirubin is produced each day, mostly from hemoglobin released as red cells reach the end of their 120-day life. This unconjugated bilirubin is fat-soluble, travels bound to albumin and cannot be excreted. Liver cells take it up and attach one or two glucuronic acid molecules (conjugation, by the enzyme UGT1A1), producing water-soluble conjugated bilirubin that is pumped into bile and leaves the body in stool, where bacteria convert it to the brown pigments that color stool. A small amount is reabsorbed and excreted in urine as urobilinogen.

The lab measures direct bilirubin with the diazo reaction. Conjugated bilirubin reacts directly with the reagent, hence the name; unconjugated bilirubin reacts only after an accelerator is added, giving the total. Indirect bilirubin is the difference. The method is slightly imperfect: a little unconjugated bilirubin reacts directly, so healthy people show a measured direct of 0.1 to 0.3 mg/dL even though their true conjugated level is near zero, and newer assays that measure conjugated bilirubin specifically read lower.

When bilirubin has been high for more than a week or two, some conjugated bilirubin binds covalently to albumin to form delta bilirubin, which is measured as direct, is not filtered by the kidney and clears only as albumin does, with a half-life of about 2 to 3 weeks. That is why the direct bilirubin can stay raised for weeks after a bile duct has been cleared or hepatitis has resolved, while urine bilirubin becomes negative and the person feels well. Fasting does not raise direct bilirubin (it raises indirect bilirubin in Gilbert's syndrome), and there is no meaningful daily rhythm.

Normal range for Direct bilirubin

Reference ranges vary between labs and by age, sex and pregnancy. Use the range printed on your own report.

Group	Typical range (mg/dL (SI µmol/L; 1 mg/dL = 17.1 µmol/L))	Notes
Adults, direct bilirubin	0.0–0.3 mg/dL (0–5 µmol/L)	Some labs use 0.2 or 0.4 mg/dL as the upper limit. Labs differ; use the printed range.
Adults, total bilirubin	0.1–1.2 mg/dL	Direct plus indirect. Jaundice becomes visible in the whites of the eyes at a total of about 2.5–3 mg/dL.
Adults, indirect bilirubin (calculated)	About 0.1–1.0 mg/dL	Total minus direct. Raised alone in hemolysis and Gilbert's syndrome.
Direct as a share of total, healthy	Under about 20 percent	Much of the measured 'direct' in health is assay cross-reaction rather than true conjugated bilirubin.
Unconjugated-predominant hyperbilirubinemia	Direct under 20 percent of a raised total	Hemolysis, Gilbert's syndrome, resorbing hematoma, ineffective red cell production.
Mixed hyperbilirubinemia	Direct 20–50 percent of a raised total	Common in hepatocellular disease: viral and alcoholic hepatitis, cirrhosis, drug injury.
Conjugated-predominant hyperbilirubinemia	Direct over 50 percent of a raised total	Bile duct obstruction, intrahepatic cholestasis, Dubin-Johnson and Rotor syndromes. Urine bilirubin is positive.
Marked elevation	Direct above about 5 mg/dL (total above 10)	Complete bile duct obstruction, severe alcoholic or viral hepatitis, sepsis-related cholestasis, advanced cirrhosis. Totals above 25–30 mg/dL are unusual with obstruction alone and suggest added liver cell failure or hemolysis.
Infants	Direct up to 1.0 mg/dL	Above 1.0 mg/dL is abnormal at any total (NASPGHAN/ESPGHAN 2017) and needs evaluation for biliary atresia, ideally before 30 to 45 days of age.

High direct bilirubin

A high direct bilirubin means conjugated bilirubin is backing up into the blood instead of leaving in bile. The two broad mechanisms are obstruction and liver cell injury, and the other liver enzymes usually say which. In obstruction (cholestasis) alkaline phosphatase rises to more than two or three times its upper limit with GGT alongside it, while ALT and AST rise less; the causes are gallstones lodged in the common bile duct, cancers of the pancreatic head, bile duct or ampulla, bile duct strictures, primary biliary cholangitis and primary sclerosing cholangitis. In liver cell injury (hepatocellular) ALT and AST rise many times above normal with a smaller alkaline phosphatase rise; the causes are viral hepatitis A, B, C and E, alcoholic hepatitis, drug-induced liver injury, autoimmune hepatitis and ischemic injury. Clinicians use the R ratio, (ALT divided by its upper limit) over (alkaline phosphatase divided by its upper limit): above 5 is hepatocellular, below 2 is cholestatic, in between is mixed.

Direct bilirubin does not rise alone for long. A direct bilirubin of 0.4 to 0.6 mg/dL with a normal total and normal enzymes is often assay noise or delta bilirubin from a past episode and is simply repeated. A direct bilirubin above 1 mg/dL with raised enzymes is a real signal. Dark urine and pale stools point to cholestasis; itching is characteristic of it; right upper abdominal pain with fever suggests infected bile behind a stone (cholangitis), which is an emergency; painless jaundice with weight loss in an older adult raises concern about cancer of the pancreas or bile duct; and jaundice with confusion, bruising or a rising INR means the liver is failing.

Two inherited conditions cause a lifelong mildly raised direct bilirubin (typically total 2 to 5 mg/dL, more than half direct) with completely normal enzymes, no itching and no liver damage: Dubin-Johnson syndrome and Rotor syndrome. They are rare, harmless and need no treatment beyond knowing about them so that the result is not chased repeatedly. In cirrhosis of any cause, bilirubin rises as the liver fails and is one of the components of the Child-Pugh and MELD scores used to grade severity and prioritise transplant.

Common causes

Gallstones in the common bile duct (choledocholithiasis)
A stone blocks bile outflow, raising direct bilirubin and alkaline phosphatase, often with right upper abdominal pain after meals. Fever and chills added to that (Charcot's triad) mean cholangitis, an infection behind the blockage that needs same-day treatment. Up to 15 percent of people with gallstones have duct stones at some point.
Pancreatic, bile duct and ampullary cancer
A tumor at the head of the pancreas or in the bile duct compresses the duct and produces progressive, often painless jaundice with weight loss, pale stools and a palpable gallbladder. Direct bilirubin can climb above 10 mg/dL. CA 19-9 and imaging follow the ultrasound.
Viral hepatitis
Hepatitis A, B, C and E injure liver cells, producing a mixed picture with ALT and AST in the hundreds to thousands, bilirubin usually 2 to 10 mg/dL and roughly half direct. Hepatitis A and E are typically self-limiting; B and C need serology and follow-up.
Alcoholic hepatitis and alcohol-related cirrhosis
Heavy drinking causes an AST-predominant injury (AST:ALT ratio above 2) with bilirubin that can exceed 10 mg/dL in severe alcoholic hepatitis; a bilirubin above 3 mg/dL with a raised INR after a drinking binge defines a dangerous episode. The bilirubin level at day 7 predicts survival.
Drug-induced liver injury
Amoxicillin-clavulanate, flucloxacillin, anabolic steroids, estrogens, azathioprine, isoniazid, many antibiotics and herbal and dietary supplements (green tea extract, kava, bodybuilding products) cause cholestatic or mixed injury. Jaundice with a hepatocellular injury (Hy's law) carries a roughly 10 percent risk of death or transplant.
Primary biliary cholangitis and primary sclerosing cholangitis
Autoimmune destruction of small bile ducts (PBC, mostly in women, with a positive antimitochondrial antibody) or inflammatory scarring of larger ducts (PSC, often with ulcerative colitis) raises alkaline phosphatase first and direct bilirubin as the disease advances; a rising bilirubin is the main marker of progression.
Sepsis and critical illness
Bacterial toxins and inflammatory cytokines impair bile transport, so direct bilirubin rises in severe infection even when the liver and bile ducts are structurally normal; it resolves as the infection is treated. Intravenous feeding (TPN) and major surgery do the same.
Cholestasis of pregnancy
Intrahepatic cholestasis of pregnancy causes itching in the third trimester with raised bile acids (above 10 µmol/L) and sometimes a modest rise in direct bilirubin; bile acids above 100 µmol/L carry a stillbirth risk and change delivery planning.
Dubin-Johnson and Rotor syndromes
Inherited defects in moving conjugated bilirubin out of liver cells (Dubin-Johnson) or in its reuptake (Rotor) cause a lifelong mild conjugated hyperbilirubinemia, typically a total of 2 to 5 mg/dL, with normal enzymes and no liver damage. No treatment is needed.
Biliary atresia and other causes of infant cholestasis
In newborns a direct bilirubin above 1.0 mg/dL, pale stools or jaundice lasting beyond 2 weeks (3 weeks if breastfed) must be assessed promptly. Biliary atresia blocks the ducts and the corrective Kasai operation works best before 45 to 60 days of age.

Symptoms that can go with it

Dark, tea- or cola-colored urine, often the first sign because conjugated bilirubin is water-soluble
Yellowing of the whites of the eyes, then the skin, once total bilirubin passes about 2.5–3 mg/dL
Pale, clay-colored or greasy stools when bile is not reaching the intestine
Itching, often worse at night and on the palms and soles, with cholestasis
Pain in the right upper abdomen, sometimes spreading to the back or shoulder, with gallstones
Fever, chills and rigors with pain and jaundice (cholangitis), which is an emergency
Loss of appetite, nausea, fatigue and weight loss
Confusion, drowsiness or easy bruising, which indicate the liver is failing

Read it alongside

Total and indirect bilirubin — the split decides whether the problem is production or conjugation (indirect) or excretion and bile flow (direct).
Alkaline phosphatase and GGT — rise together in bile duct obstruction and cholestasis; a high ALP with a normal GGT suggests bone, not liver.
ALT and AST — rise most in liver cell injury; the R ratio of ALT to ALP separates hepatocellular from cholestatic patterns, and an AST:ALT ratio above 2 suggests alcohol.
Urine bilirubin and urobilinogen — bilirubin in urine confirms the conjugated fraction is high; absent urobilinogen with positive urine bilirubin suggests complete obstruction.
Albumin and PT/INR — measure what the liver is still making; a rising INR with jaundice signals liver failure.
Lipase — a stone at the lower bile duct or a pancreatic tumor often raises lipase as well.
CBC, reticulocyte count, LDH and haptoglobin — ordered when the indirect fraction is the one that is high, to look for hemolysis.
Hepatitis A, B, C and E serology, antimitochondrial antibody, ANA and immunoglobulins — identify viral and autoimmune causes once ultrasound has excluded obstruction.

What usually happens next

The enzyme pattern is read first: a cholestatic pattern (ALP more than three times normal, modest ALT) or a hepatocellular pattern (ALT more than ten times normal) with the direct bilirubin sets the direction.
An ultrasound of the liver, bile ducts, gallbladder and pancreas is the first imaging test, usually within days; dilated ducts mean obstruction and lead to MRCP, endoscopic ultrasound or ERCP, which can remove a stone or place a stent.
If the ducts are not dilated, blood tests for viral hepatitis, autoimmune liver disease and iron and copper studies follow, together with a careful review of every medication and supplement started in the previous 3 months.
Albumin, INR and platelets are tracked to judge how well the liver is functioning; a rising INR changes the urgency entirely.
A mildly raised direct bilirubin (0.4 to 0.8 mg/dL) with normal enzymes and no symptoms is usually repeated in 4 to 8 weeks; if it persists, Dubin-Johnson or Rotor syndrome or residual delta bilirubin is considered.
For a newborn with a direct bilirubin above 1.0 mg/dL, referral to a pediatric liver specialist is immediate, because the window for treating biliary atresia is measured in weeks.

Diet, lifestyle and natural levers with evidence

What can move Direct bilirubin once the cause is known. Nothing here replaces finding the cause.

Stopping alcohol

Strong evidence

In alcohol-related liver disease, abstinence is the intervention with the largest effect on survival in every cohort studied, and bilirubin is the marker that tracks it: in alcoholic hepatitis, a fall in bilirubin by day 7 (the Lille score) is the strongest predictor of surviving the episode, and in cirrhosis sustained abstinence improves bilirubin, albumin and INR over 3 to 6 months in people who have not yet reached end-stage disease. Continued drinking roughly halves five-year survival compared with abstinence in alcohol-related cirrhosis.

Weight loss for fatty liver disease

Moderate evidence

In a prospective study of 293 people with biopsy-proven non-alcoholic steatohepatitis, losing 10 percent or more of body weight over a year through diet and exercise resolved the steatohepatitis in 90 percent and improved fibrosis in 45 percent; losing 5 to 7 percent improved inflammation in about half. Bilirubin is usually normal or only mildly raised in fatty liver disease, so the lever acts on the underlying injury rather than the number itself.

Coffee

Moderate evidence

A meta-analysis of nine cohort studies covering about 430,000 people found that each additional two cups of coffee a day was associated with a 44 percent lower risk of cirrhosis (relative risk 0.56), with consistent findings across alcohol-related and non-alcoholic liver disease and for liver cancer. The evidence is observational, so it supports not avoiding coffee if you have liver disease rather than drinking it as a treatment; it does not lower an already raised bilirubin.

Avoiding hepatotoxic supplements and limiting acetaminophen

Strong evidence

Herbal and dietary supplements accounted for about 20 percent of drug-induced liver injury cases in the US Drug-Induced Liver Injury Network by 2013 to 2014, up from 7 percent a decade earlier, with bodybuilding products containing anabolic steroids causing prolonged cholestatic jaundice and green tea extract, kava and multi-ingredient weight-loss products causing hepatocellular injury. Stopping the product is the treatment; recovery of bilirubin typically takes weeks to months. Acetaminophen is safe at up to 2 to 3 g a day in stable liver disease but is the commonest cause of acute liver failure in overdose.

Tell your clinician about every supplement, including protein powders, pre-workout and weight-loss products; many are not labelled with their active ingredients.

Milk thistle (silymarin)

Preliminary evidence

A Cochrane review of 13 randomised trials in alcoholic and viral liver disease found no reliable effect of milk thistle on mortality or liver histology, and the larger US trial in hepatitis C found no change in ALT. Some small trials report modest ALT reductions in fatty liver disease. There is no good evidence that it lowers direct bilirubin or helps obstruction, and it should not delay evaluation of a raised result.

Generally well tolerated; can interact with drugs metabolized by CYP2C9 and may lower blood glucose alongside diabetes medication.

Knowing what fasting does and does not do

Strong evidence

Fasting for 24 to 48 hours raises indirect bilirubin two- to three-fold in people with Gilbert's syndrome, and a long overnight fast before a blood draw can tip indirect bilirubin just over the range in anyone. It has no effect on direct bilirubin. If your direct fraction is the raised one, a fast or a missed breakfast is not the explanation, and the result deserves the enzyme and ultrasound work-up rather than a 'repeat after eating'.

When to see a clinician promptly

Jaundice with fever, chills or shaking, and pain in the right upper abdomen: cholangitis (infected, blocked bile) can cause sepsis within hours and needs emergency care.
Jaundice with confusion, unusual drowsiness, bleeding gums, easy bruising or vomiting blood: signs of liver failure, needing same-day hospital assessment.
Painless jaundice with pale stools, dark urine and weight loss, especially over the age of 50: cancer of the pancreas or bile duct must be excluded within days.
Itching, dark urine or jaundice in pregnancy, so that bile acids and liver tests can be checked; cholestasis of pregnancy changes how delivery is planned.
A newborn who is still jaundiced after 2 weeks (3 weeks if breastfed), or who has pale, chalky stools at any age, must have a direct bilirubin measured promptly; above 1.0 mg/dL needs urgent specialist referral.
Any direct bilirubin above 1 mg/dL, or a direct bilirubin that is rising on a repeat test, even without symptoms, within a week.

Frequently asked questions

What is a normal direct bilirubin level?

In adults, 0 to 0.3 mg/dL at most labs (0 to 5 µmol/L), with some using 0.2 or 0.4 mg/dL as the upper limit. Total bilirubin is normally 0.1 to 1.2 mg/dL, so direct bilirubin is a small fraction of the total in health. In newborns the limit is higher, but a direct bilirubin above 1.0 mg/dL is abnormal at any age.

What does high direct bilirubin mean?

That bilirubin the liver has already conjugated is backing up into the blood. The usual reasons are a blocked bile duct (gallstones, a stricture, a tumor of the pancreas or bile duct), injury to liver cells (viral hepatitis, alcohol, medications, sepsis), cirrhosis, or cholestasis from pregnancy or drugs. Two rare inherited conditions, Dubin-Johnson and Rotor syndromes, cause a lifelong harmless rise. Dark urine and pale stools go with it.

What is the difference between direct and indirect bilirubin?

Indirect (unconjugated) bilirubin is the raw pigment from red cell breakdown; it is fat-soluble, bound to albumin and does not appear in urine. Direct (conjugated) bilirubin has been processed by the liver so that it dissolves in water and can be excreted in bile and urine. A high indirect fraction points to hemolysis or Gilbert's syndrome; a high direct fraction points to a bile flow or liver cell problem. Labs report direct bilirubin as more than about 50 percent of the total for conjugated hyperbilirubinemia and under 20 percent for unconjugated.

Is a direct bilirubin of 0.4 or 0.5 high?

Slightly above most ranges, and on its own usually not important if total bilirubin, alkaline phosphatase, GGT, ALT and AST are normal and you have no dark urine, pale stools, itching or jaundice. The direct assay picks up a little unconjugated bilirubin, and delta bilirubin from a past episode can linger for weeks. A repeat in 4 to 8 weeks with a liver panel is the usual approach; if it persists or the enzymes are abnormal, an ultrasound follows.

Can direct bilirubin be high when total bilirubin is normal?

Occasionally, by a small amount, usually because of the assay's cross-reaction or residual delta bilirubin, and it rarely signals disease when the enzymes are normal. Early cholestasis can raise the direct fraction before the total leaves its range, so if alkaline phosphatase and GGT are also raised, or you have symptoms, the result is pursued rather than dismissed.

Does Gilbert's syndrome raise direct bilirubin?

No. Gilbert's syndrome reduces the activity of the conjugating enzyme UGT1A1, so it raises indirect (unconjugated) bilirubin, usually to a total of 1.5 to 3 mg/dL with the direct fraction under 20 percent, worse with fasting, illness and dehydration. If your direct bilirubin is the raised fraction, Gilbert's is not the explanation and another cause should be looked for.

What does a low direct bilirubin mean?

Nothing of concern. A direct bilirubin of 0.0 or 0.1 mg/dL is the expected healthy result; there is no lower limit of clinical significance. Some population studies link lower total bilirubin with slightly higher cardiovascular and metabolic risk, because bilirubin has antioxidant effects, but this applies to the total, mostly the indirect fraction, and is not something a clinician acts on.

How do I lower my direct bilirubin?

Only by treating the cause: removing a bile duct stone or stent-relieving an obstruction, stopping alcohol or the responsible drug or supplement, treating hepatitis or infection, or managing cirrhosis. There is no diet or supplement that lowers conjugated bilirubin directly. Once the cause is dealt with, the direct bilirubin falls over days to weeks, though delta bilirubin can keep the number above normal for two to three weeks after you feel well.

References

Bilirubin blood test. MedlinePlus, US National Library of Medicine (2022)View source
Bilirubin test. Mayo Clinic (2022)View source
Fargo MV, Grogan SP, Saguil A. Evaluation of jaundice in adults. American Family Physician (2017)
Kwo PY, Cohen SM, Lim JK. ACG clinical guideline: evaluation of abnormal liver chemistries. American Journal of Gastroenterology (2017)
Fawaz R, Baumann U, Ekong U, et al.. Guideline for the evaluation of cholestatic jaundice in infants: joint recommendations of NASPGHAN and ESPGHAN. Journal of Pediatric Gastroenterology and Nutrition (2017)
Fevery J. Bilirubin in clinical practice: a review. Liver International (2008)
Erlinger S, Arias IM, Dhumeaux D. Inherited disorders of bilirubin transport and conjugation: new insights into molecular mechanisms and consequences. Gastroenterology (2014)
Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases. Hepatology (2020)
Navarro VJ, Khan I, Björnsson E, Seeff LB, Serrano J, Hoofnagle JH. Liver injury from herbal and dietary supplements. Hepatology (2017)
Kennedy OJ, Roderick P, Buchanan R, Fallowfield JA, Hayes PC, Parkes J. Systematic review with meta-analysis: coffee consumption and the risk of cirrhosis. Alimentary Pharmacology and Therapeutics (2016)
Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, et al.. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology (2015)
Rambaldi A, Jacobs BP, Gluud C. Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases. Cochrane Database of Systematic Reviews (2007)
Jaundice. Merck Manual Professional Version (2024)

Related markers

Related conditions

Evidence guides

Worried about your number?

Ask AskMN what your Direct bilirubin result could mean in the context of your other results, symptoms and medications. Free, unlimited, no account needed.

Ask about my Direct bilirubin

This page is educational and is not medical advice or a diagnosis. Lab results have to be interpreted together with your history, symptoms and other results by a clinician who knows you. Do not start or stop a supplement to change a lab value before the cause is known.